Successful Treatment of Relapsing Bowen's Disease with Ingenol Mebutate: The Use of Dermoscopy to Monitor the Therapeutic Response

被引:4
作者
Mainetti, Carlo [1 ]
Guillod, Caroline [1 ]
Leoni-Parvex, Sandra [2 ]
机构
[1] Osped Reg Bellinzona & Valli, Dept Dermatol, CH-6500 Bellinzona, Switzerland
[2] Inst Pathol, Locarno, Switzerland
关键词
Ingenol mebutate; Bowen's disease; Dermoscopy; Non-melanoma skin cancers; ACTINIC KERATOSIS; GEL; GUIDELINES; MANAGEMENT; CARCINOMA;
D O I
10.1159/000447389
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Ingenol mebutate (IM) has recently been approved for the topical treatment of actinic keratoses. It appears to have a dual mechanism of action: rapid necrosis after gel application and a subsequent immune-mediated response, which targets any residual dysplastic epidermal cells. We report the successful treatment of a woman, who had been relapsing into Bowen's disease (BD) on her right forefinger for 8 years. During her clinical history, she had received an allogeneic, HLA-identical stem cell transplant for myeloproliferative syndrome with a JAK2V617F mutation and lobectomy of the pulmonary right lower lobe for adenocarcinoma. We used dermoscopy to monitor the therapeutic response of BD. We discuss IM gel as a possible therapeutic option for BD. (C) 2016 S. Karger AG, Basel
引用
收藏
页码:9 / 13
页数:5
相关论文
共 19 条
[1]   Vascular structures in skin tumors - A dermoscopy study [J].
Argenziano, G ;
Zalaudek, I ;
Corona, R ;
Sera, F ;
Cicale, L ;
Petrillo, G ;
Ruocco, E ;
Hofmann-Wellenhof, R ;
Soyer, HP .
ARCHIVES OF DERMATOLOGY, 2004, 140 (12) :1485-1489
[2]  
Braun SA, 2014, HAUTARZT, V65, P848, DOI [10.1007/s00105-014-3509-5, 1]
[3]   Guidelines for management of Bowen's disease: 2006 update [J].
Cox, N. H. ;
Eedy, D. J. ;
Morton, C. A. .
BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (01) :11-21
[4]   Ingenol Mebutate Field-Directed Treatment of UVB-Damaged Skin Reduces Lesion Formation and Removes Mutant p53 Patches [J].
Cozzi, Sarah-Jane ;
Ogbourne, Steven M. ;
James, Cini ;
Rebel, Heggert G. ;
de Gruijl, Frank R. ;
Ferguson, Blake ;
Gardner, Joy ;
Lee, Thuy T. ;
Larcher, Thibaut ;
Suhrbier, Andreas .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (04) :1263-1271
[5]   Ingenol Mebutate Signals via PKC/MEK/ERK in Keratinocytes and Induces Interleukin Decoy Receptors IL1R2 and IL13RA2 [J].
Freiberger, Sandra N. ;
Cheng, Phil F. ;
Iotzova-Weiss, Guergana ;
Neu, Johannes ;
Liu, Qinxiu ;
Dziunycz, Piotr ;
Zibert, John R. ;
Dummer, Reinhard ;
Skak, Kresten ;
Levesque, Mitchell P. ;
Hofbauer, Guenther F. L. .
MOLECULAR CANCER THERAPEUTICS, 2015, 14 (09) :2132-2142
[6]   Swiss clinical practice guidelines on field cancerization of the skin [J].
Hofbauer, Guenther ;
Anliker, Mark ;
Boehncke, Wolf-Henning ;
Brand, Christoph ;
Braun, Ralph ;
Gaide, Olivier ;
Hafner, Juerg ;
Hunger, Robert ;
Itin, Peter ;
Kaeuper, Gina ;
Lautenschlager, Stephan ;
Mainetti, Carlo ;
Streit, Markus .
SWISS MEDICAL WEEKLY, 2014, 144
[7]   Ingenol Mebutate Gel for Actinic Keratosis [J].
Lebwohl, Mark ;
Swanson, Neil ;
Anderson, Lawrence L. ;
Melgaard, Anita ;
Xu, Zhenyi ;
Berman, Brian .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (11) :1010-1019
[8]   Successful treatment of Bowen's disease with ingenol mebutate 0.05% gel [J].
Lee, Joo Hee ;
Lee, Ji Hae ;
Bae, Jung Min ;
Kim, Gyong Moon .
JOURNAL OF DERMATOLOGY, 2015, 42 (09) :920-921
[9]   Dermoscopy and Reflectance Confocal Microscopy for Monitoring the Treatment of Actinic Keratosis with Ingenol Mebutate Gel: Report of Two Cases [J].
Longo, Caterina ;
Borsari, Stefania ;
Benati, Elisa ;
Moscarella, Elvira ;
Alfano, Roberto ;
Argenziano, Giuseppe .
DERMATOLOGY AND THERAPY, 2016, 6 (01) :81-87
[10]   Topical pharmacotherapy for skin cancer [J].
Micali, Giuseppe ;
Lacarrubba, Francesco ;
Nasca, Maria Rita ;
Ferraro, Salvatore ;
Schwartz, Robert A. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (06) :965.e1-965.e12